GO:1905006 negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation: Heart Valve Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905006 describes any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition (EMT) specifically during endocardial cushion formation, a critical step in heart valve development.
• Endocardial cushion formation requires a precisely timed EMT in which endocardial cells delaminate, invade the cardiac jelly and contribute to valve primordia; negative regulation of this EMT ensures proper cushion size and valve morphogenesis.
• Notch signaling is a key ligand-dependent pathway that sequentially regulates valve primordium formation and morphogenesis, and its modulation is directly relevant to negative regulation of endocardial EMT.
• Dysregulation of endocardial cushion EMT is linked to congenital heart valve defects such as bicuspid aortic valve and other valve malformations.
• Researchers study GO:1905006 using lineage tracing, explant assays, gene knockout and knock-in models, and transcriptomic/proteomic profiling of endocardial cells.
• CRISPR-based knockout, point mutation, knock-in and overexpression models enable causal testing of candidate regulators of endocardial cushion EMT.
Description
GO:1905006, negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation, is a biological process term that captures the braking mechanisms which restrain EMT during a specific developmental window: the formation of endocardial cushions. Endocardial cushions are precursor structures that give rise to heart valves and septa, and their formation depends on a tightly controlled EMT in which endocardial cells transform into mesenchymal cells and invade the cardiac jelly. Without negative regulation, excessive or mistimed EMT can lead to malformed cushions and downstream valve defects. This term is therefore central to developmental cardiology and to understanding congenital heart disease mechanisms. For researchers, GO:1905006 provides a precise annotation target when studying how signaling pathways, transcription factors and extracellular cues limit endocardial EMT. Because the process is embedded in a complex morphogenetic program, its study requires combining developmental biology, imaging, and genetic perturbation. The term also helps organize functional genomics data, allowing investigators to distinguish general EMT regulators from those specifically acting in endocardial cushion formation.
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation At A Glance
| GO ID | GO:1905006 |
|---|---|
| GO term | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| Ontology | biological_process |
| Synonym | down regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; down-regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; downregulation of epithelial to mesenchymal transition involved in endocardial cushion formation; inhibition of epithelial to mesenchymal transition involved in endocardial cushion formation |
| Major function | Restrains EMT during endocardial cushion formation to ensure proper heart valve primordium size and morphogenesis |
| Developmental context | Endocardial cushion formation in the embryonic heart, a precursor to valve and septal structures |
| Key signaling pathway | Notch signaling, which sequentially regulates valve primordium formation and morphogenesis |
| Research relevance | Congenital heart valve defects, bicuspid aortic valve, and mechanistic studies of EMT control |
What Is GO:1905006?
In plain terms, GO:1905006 refers to any biological process that stops, prevents or reduces the frequency, rate or extent of the epithelial to mesenchymal transition that occurs during endocardial cushion formation. It is a negative regulatory process term, meaning it does not describe the EMT itself but the mechanisms that restrain it. The definition is intentionally broad: it includes signaling events, transcriptional changes, cell adhesion remodeling and any other process that quantitatively or qualitatively limits endocardial EMT. This specificity distinguishes it from general negative regulation of EMT, because the context is restricted to endocardial cushion formation in the developing heart.
Why Is negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation Important in Cell Biology?
GO:1905006 matters because the negative regulation of endocardial EMT is a decisive checkpoint in heart valve development. When this brake fails, endocardial cells may undergo excessive or poorly timed EMT, leading to abnormal cushion size and subsequent valve malformations. Conversely, excessive negative regulation could produce hypocellular cushions and valve hypoplasia. Understanding this process therefore informs the molecular basis of congenital heart disease and provides candidate targets for diagnostic or therapeutic strategies. The term also serves as a functional annotation hub, helping researchers interpret gene expression and perturbation data in the context of a specific developmental EMT event rather than generic EMT.
• Defines a precise developmental checkpoint that controls heart valve primordium size and shape.
• Links Notch signaling and other pathways to endocardial cushion morphogenesis.
• Provides a framework for interpreting congenital heart valve defect mechanisms.
• Helps distinguish general EMT regulators from endocardial-specific ones.
• Supports functional genomics and single-cell studies of endocardial lineages.
• Guides CRISPR perturbation design for causal testing of candidate genes.
• Relevant to tissue engineering and regenerative approaches for valve disease.
• Connects developmental biology to pediatric cardiology and genetics.
• Enables cross-species comparison of valve development mechanisms.
• Facilitates annotation of high-throughput datasets with a specific biological process.
What Happens During negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation?
Initiation of endocardial EMT and the need for negative regulation
In simple terms: Endocardial cells first need to transform into migratory mesenchymal cells to build the heart cushions, but this must be kept in check.
During endocardial cushion formation, a subset of endocardial cells undergoes EMT, delaminating from the endocardial monolayer and invading the cardiac jelly. This process is essential for valve primordium formation, but it must be negatively regulated to prevent excessive or ectopic EMT. Notch signaling has been shown to sequentially regulate valve primordium formation and morphogenesis, providing a ligand-dependent mechanism that can restrain or shape EMT timing. The negative regulation described by GO:1905006 therefore acts at the initiation stage to set the threshold for how many cells undergo EMT and when.
Signaling pathways that restrain endocardial EMT
In simple terms: Several signaling pathways act as brakes on the transformation of endocardial cells.
Negative regulation of endocardial EMT involves signaling inputs that oppose pro-EMT cues. Notch signaling is a key ligand-dependent pathway that regulates valve primordium formation and morphogenesis, and its sequential activation can modulate the extent of EMT. Other pathways, including TGF-beta/BMP and Wnt, are known to influence EMT in various contexts, but their specific negative regulatory roles in endocardial cushion formation require careful annotation. GO:1905006 captures any process that reduces the frequency, rate or extent of this EMT, including signaling events that inhibit delamination or invasion.
Transcriptional and epigenetic control of the negative regulation
In simple terms: Genes can be switched on or off to keep the EMT in check.
Transcriptional programs that repress mesenchymal genes or maintain endothelial identity contribute to negative regulation of endocardial EMT. While specific transcription factors for this exact process are still being defined, the general principle is that negative regulators act by sustaining endothelial gene expression, preventing mesenchymal activation, or promoting cell-cell adhesion. Notch signaling can influence transcriptional states in valve primordia, supporting a role in this regulatory layer. Epigenetic modifiers may also set the responsiveness of endocardial cells to EMT-inducing signals, but further studies are needed to assign specific factors to GO:1905006.
Cellular and morphological outcomes of negative regulation
In simple terms: The result is a properly sized cushion with the right number of mesenchymal cells.
When negative regulation is effective, endocardial EMT is limited to the appropriate region and developmental time, yielding endocardial cushions of correct size and cellularity. This ensures that valve primordia form normally and that subsequent morphogenesis can proceed. Notch signaling has been shown to regulate valve primordium formation and morphogenesis in a sequential, ligand-dependent manner, highlighting how negative regulation can be integrated with positive morphogenetic signals. Disruption of this balance can lead to cushion hyperplasia or hypoplasia, both of which are associated with congenital valve defects.
Integration with valve morphogenesis
In simple terms: The brakes on EMT are part of the larger process that sculpts heart valves.
Negative regulation of endocardial EMT is not an isolated event but is integrated with the broader program of valve morphogenesis. After cushions form, they undergo remodeling, elongation and stratification to produce mature valve leaflets. Notch signaling continues to play roles in these later steps, as shown by sequential ligand-dependent activation during valve primordium formation and morphogenesis. Therefore, GO:1905006 should be viewed as one module within a dynamic regulatory network that coordinates EMT timing with subsequent valve development.
Key Genes Involved in GO:1905006 negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
The following genes and proteins have been implicated in endocardial cushion formation, EMT regulation, or Notch signaling relevant to GO:1905006, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Notch receptor that mediates ligand-dependent signaling in valve primordium formation | Key regulator of endocardial EMT and valve morphogenesis; mutations linked to valve disease |
| JAG1 | Notch ligand that activates Notch signaling in endocardial cells | Ligand-dependent activation of Notch during valve primordium formation |
| DLL4 | Notch ligand involved in endothelial-to-mesenchymal signaling | Modulates Notch activity in endocardial cushion formation |
| HEY1 | Notch target transcription factor | Readout of Notch signaling in valve development |
| HEY2 | Notch target transcription factor | Regulates endocardial EMT and valve morphogenesis |
| HES1 | Notch target transcriptional repressor | Can restrain EMT by repressing mesenchymal genes |
| SNAI1 | EMT-inducing transcription factor | Pro-EMT factor whose activity is counteracted by negative regulation |
| SNAI2 | EMT-inducing transcription factor | Contributes to endocardial EMT; target of negative regulation |
| TWIST1 | EMT-associated transcription factor | Promotes mesenchymal phenotype in cushion cells |
| CDH5 | Endothelial adherens junction protein | Maintains endothelial identity; loss promotes EMT |
| VIM | Mesenchymal intermediate filament | Marker of EMT in endocardial cells |
| ACTA2 | Smooth muscle actin | Marker of mesenchymal transition in cushion cells |
| TGFB1 | Pro-EMT growth factor | Can induce endocardial EMT; negative regulators oppose its effects |
| BMP2 | Signaling molecule in cushion formation | Promotes EMT in endocardial cushions; subject to negative regulation |
| WNT5A | Non-canonical Wnt ligand | Modulates EMT and cushion morphogenesis |
| NFATC1 | Transcription factor in valve development | Regulates endocardial cushion remodeling |
| GATA4 | Cardiac transcription factor | Essential for heart development; mutations linked to valve defects |
| TBX20 | Cardiac transcription factor | Regulates valve development and endocardial EMT |
How Is negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation Regulated?
Negative regulation of endocardial EMT is itself controlled by upstream signals and transcriptional networks. Notch signaling is a central ligand-dependent pathway that sequentially regulates valve primordium formation and morphogenesis, and its activation state can determine whether EMT is promoted or restrained. The pathway is modulated by ligand availability (e.g., JAG1, DLL4) and receptor expression (e.g., NOTCH1), creating a dynamic balance. Other pathways such as TGF-beta/BMP and Wnt intersect with Notch to fine-tune EMT. While specific upstream regulators of GO:1905006 are still being mapped, the general principle is that negative regulation integrates developmental cues to ensure proper cushion size and valve morphogenesis.
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Bicuspid aortic valve, valve calcification | Knockout or point-mutation in endocardial cells; lineage tracing |
| JAG1 | Alagille syndrome with valve defects | Knock-in of patient mutations; ligand-dependent Notch activation assays |
| HEY2 | Congenital heart valve malformations | Knockout and overexpression in cushion explants |
| GATA4 | Congenital heart defects including valve anomalies | Knockout and knock-in in cardiac lineages |
| TBX20 | Valve and septal defects | Conditional knockout; transcriptomic profiling |
Congenital heart valve defects
Disruption of negative regulation of endocardial EMT can lead to abnormal endocardial cushion formation, which is a precursor to congenital heart valve defects such as bicuspid aortic valve and other valve malformations. Notch signaling, a key regulator of valve primordium formation and morphogenesis, has been implicated in these defects. Understanding GO:1905006 provides a mechanistic framework for how mutations or dysregulated signaling contribute to valve disease.
Bicuspid aortic valve and related anomalies
Bicuspid aortic valve is a common congenital anomaly often linked to defective endocardial cushion development. Because Notch signaling sequentially regulates valve primordium formation and morphogenesis, perturbations in this pathway can affect cushion EMT and subsequent valve leaflet number and shape. Negative regulation of EMT is therefore relevant to the etiology of bicuspid aortic valve and associated aortopathy.
Other developmental syndromes with valve involvement
Syndromes such as Alagille syndrome, caused by JAG1 mutations, and other Notch-related disorders feature valve and cardiac defects. These conditions highlight the importance of ligand-dependent Notch signaling in endocardial cushion formation and valve morphogenesis. GO:1905006 helps organize the study of how negative regulation of EMT contributes to these syndromic presentations.
From negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate endocardial EMT? | Endothelial-specific knockout in mouse; explant EMT assay |
| Does a point mutation in NOTCH1 alter EMT restraint? | CRISPR point-mutation knock-in in endocardial cells |
| How does ligand-dependent Notch activation affect cushion size? | Inducible overexpression of JAG1 or DLL4 in endocardium |
| What is the transcriptional signature of negative regulation? | RNA-seq of sorted endocardial cells from knockout vs control |
| Where and when is the regulator expressed? | Tagged knock-in reporter (e.g., GFP) and lineage tracing |
| Can a candidate gene rescue EMT overactivation? | Overexpression rescue in knockout background |
How to Study the negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Origin and fate of endocardial cells undergoing EMT | Assess extent of EMT in vivo |
| Explant collagen gel assay | Number of invasive mesenchymal cells | Quantify EMT in vitro |
| Single-cell RNA-seq | Transcriptional states of endocardial and mesenchymal cells | Identify regulators and markers |
| Immunofluorescence | Protein localization and EMT markers (e.g., CDH5, VIM) | Validate EMT phenotype |
| CRISPR knockout | Loss-of-function effect on EMT | Test candidate negative regulators |
| CRISPR knock-in | Tagged or mutant protein function | Study point mutations or reporters |
| Overexpression | Gain-of-function effect on EMT | Test sufficiency of negative regulation |
Lineage tracing and imaging
Lineage tracing using Cre-lox or similar systems allows visualization of endocardial cells undergoing EMT and their contribution to cushion mesenchyme. Confocal or light-sheet imaging can quantify delamination and invasion. These methods are essential to assess the frequency and extent of EMT, which is the target of negative regulation described by GO:1905006.
Explant and collagen gel assays
Endocardial cushion explants cultured on collagen gels provide a tractable in vitro system to measure EMT. Cells that undergo EMT invade the gel and can be counted. This assay can be combined with pharmacological or genetic perturbation to test negative regulators of EMT.
Transcriptomics and single-cell RNA-seq
RNA-seq of endocardial cells or single-cell RNA-seq of cushion tissue can reveal gene expression changes associated with negative regulation of EMT. Notch target genes such as HEY1, HEY2 and HES1 can serve as readouts of pathway activity. These methods help identify downstream effectors of GO:1905006.
Genetic perturbation with CRISPR
CRISPR-Cas9 knockout, point mutation, knock-in and overexpression models enable causal testing of candidate genes in endocardial EMT. For example, knocking out a putative negative regulator should increase EMT, while overexpression should reduce it. These approaches are directly aligned with studying GO:1905006.
How CRISPR Can Be Used to Study GO:1905006 negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
Knockout
CRISPR knockout of a candidate gene in endocardial cells or model organisms can test whether it is required for negative regulation of endocardial EMT. If knockout increases EMT frequency or cushion size, the gene likely contributes to GO:1905006. Notch pathway components such as NOTCH1, JAG1 and HEY2 are prime candidates for such studies.
Point Mutation
Point mutations identified in patients with valve defects can be introduced via CRISPR to assess their impact on negative regulation of EMT. For example, missense mutations in NOTCH1 may impair its ability to restrain EMT, providing mechanistic insight into disease.
Knock-in
Knock-in of reporter tags (e.g., GFP) or conditional alleles allows precise tracking of gene expression and function during endocardial cushion formation. This is useful for lineage tracing and for isolating cells for transcriptomics, thereby linking gene activity to GO:1905006.
Overexpression
CRISPR activation or transgenic overexpression can test whether a candidate gene is sufficient to negatively regulate endocardial EMT. Overexpression of Notch ligands or receptors may reduce EMT and alter cushion morphology, supporting a role in GO:1905006.
How EDITGENE Supports negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation Research
Researchers studying negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation-related genes often need to determine whether a candidate gene is causally involved in restraining EMT, and whether its perturbation alters valve development. This requires precise genetic models that can knockout, mutate, tag or overexpress the gene of interest in relevant cell types. EDITGENE provides a suite of CRISPR-based services to enable such studies, from single-gene perturbation to library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation research.
Frequently Asked Questions About negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
What is GO:1905006?
GO:1905006 is a Gene Ontology biological process term for any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
What does negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation mean?
It refers to the biological brakes that limit EMT during the formation of endocardial cushions, the precursor structures of heart valves.
What genes are involved in negative regulation of endocardial EMT?
Genes in the Notch signaling pathway, such as NOTCH1, JAG1, HEY1, HEY2 and HES1, are key players, along with EMT-related transcription factors like SNAI1 and SNAI2.
Why is negative regulation of endocardial EMT important?
It ensures proper cushion size and valve morphogenesis; dysregulation can lead to congenital heart valve defects such as bicuspid aortic valve.
How is Notch signaling related to GO:1905006?
Notch signaling sequentially regulates valve primordium formation and morphogenesis, and ligand-dependent activation can restrain endocardial EMT, contributing to negative regulation.
What diseases are linked to defects in endocardial cushion EMT?
Congenital heart valve defects, including bicuspid aortic valve, and syndromic conditions like Alagille syndrome with valve involvement.
How can researchers study GO:1905006?
Using lineage tracing, explant assays, transcriptomics, and CRISPR knockout, point mutation, knock-in and overexpression models in endocardial cells.
What model systems are used for endocardial EMT research?
Mouse models, zebrafish, chick embryos, and cell culture explant systems are commonly used, combined with genetic perturbation.
Can CRISPR be used to study negative regulation of endocardial EMT?
Yes, CRISPR knockout, point mutation, knock-in and overexpression enable causal testing of candidate genes in this process.
What services does EDITGENE offer for GO:1905006 research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening and bioinformatics services tailored to endocardial EMT studies.
Conclusion
GO:1905006 captures a critical developmental checkpoint: the negative regulation of EMT during endocardial cushion formation. This process ensures that heart valve primordia form with correct size and cellularity, and its disruption is linked to congenital valve defects. Notch signaling is a central pathway in this regulation, with ligand-dependent activation sequentially controlling valve primordium formation and morphogenesis. Studying GO:1905006 requires integrated approaches, from lineage tracing and explant assays to CRISPR-based perturbation and transcriptomics. By leveraging these tools, researchers can uncover new regulators and translate findings into better understanding of valve disease.
References
- 1. MacGrogan D et al.. 2016. Sequential Ligand-Dependent Notch Signaling Activation Regulates Valve Primordium Formation and Morphogenesis.. Circ Res 118(10):1480-97 PMID: 27056911
